Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...

Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...

The U.S. Justice Department has launched an investigation into UnitedHealth's Medicare billing practices in recent months, ...

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Follow us ...

Email us at: [email protected], Visit our website at: www.howardsmithlaw.com. To be a member of the class action you need not take any action at this time; you may retain counsel of ...

announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates ...

Unlicensed pharmacies purporting to sell pharmaceutical drugs are thriving despite the efforts by the U.S. Drug Enforcement Administration to stop them.

A Florida pharmaceutical company and its CEO have agreed to pay over $350,000 to the Florida Medicaid program as part of a multistate settlement resolving allegations of a kickback scheme. QOL Medical ...

Hill Health Law Group’s Amanda Hill analyzes recent fraud enforcement in health care, noting that physicians who don’t accept ...

Pinpointing the genesis of “waste, fraud and abuse” as political rhetoric is difficult. But the concept and resulting battles ...

Trump on Tuesday announced he would unveil an aggressive set of tariffs, confirming the worst fears of manufacturers across the auto, semiconductor, and pharmaceutical industries.

Avoiding a second trial, a former pharmaceutical rep who prosecutors said generated more than $10 million in wrongful insurance reimbursements pleaded guilty Tuesday to perjury in U.S. District Court.